• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cyclerion Therapeutics, Inc. - Common Stock (NQ:CYCN)

    3.090 +0.200 (+6.92%)
    Streaming Delayed Price Updated: 2:16 PM EDT, Apr 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,996,449
    Open 2.890
    Bid (Size) 3.070 (200)
    Ask (Size) 3.110 (200)
    Prev. Close 2.890
    Today's Range 2.851 - 3.750
    52wk Range 1.027 - 8.480
    Shares Outstanding 43,524,894
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire

    Performance

    YTD
    +130.6%
    +130.6%
    1 Month
    +107.4%
    +107.4%
    3 Month
    +71.7%
    +71.7%
    6 Month
    +22.6%
    +22.6%
    1 Year
    +22.6%
    +22.6%

    More News

    Read More
    Monday's session: top gainers and losers ↗
    Via Chartmill
    Monday's session: gap up and gap down stocks ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Halper Sadeh LLC is Investigating Whether UNF, CYCN, NSA, ULYX are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Unusual volume stocks in Thursday's session ↗
    Via Chartmill
    News headline image
    CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
    From Korsana Biosciences, Inc. and Cyclerion Therapeutics, Inc.
    Via Business Wire
    News headline image
    Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
    From Cyclerion Therapeutics, Inc.
    Via GlobeNewswire
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
    Via Chartmill
    Curious about the most active stocks on Tuesday? ↗
    Via Chartmill
    News headline image
    FOCUSfactor® Beverage Emerges as a Growth Catalyst for Synergy CHC Corp. (NASDAQ: SNYR) – Alongside CYCN, ALMS, EVTV, RDZN See Why
    Via AB Newswire
    Unusual volume stocks are being observed in Tuesday's session. ↗
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
    From Cyclerion Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Wednesday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Cyclerion Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Cyclerion Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Cyclerion Therapeutics, Inc. - Common Stock trade on?
    Cyclerion Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Cyclerion Therapeutics, Inc. - Common Stock?
    The ticker symbol for Cyclerion Therapeutics, Inc. - Common Stock is CYCN on the Nasdaq Stock Market
    What is the current price of Cyclerion Therapeutics, Inc. - Common Stock?
    The current price of Cyclerion Therapeutics, Inc. - Common Stock is 3.090
    When was Cyclerion Therapeutics, Inc. - Common Stock last traded?
    The last trade of Cyclerion Therapeutics, Inc. - Common Stock was at 04/09/26 02:16 PM ET
    What is the market capitalization of Cyclerion Therapeutics, Inc. - Common Stock?
    The market capitalization of Cyclerion Therapeutics, Inc. - Common Stock is 134.49M
    How many shares of Cyclerion Therapeutics, Inc. - Common Stock are outstanding?
    Cyclerion Therapeutics, Inc. - Common Stock has 134M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.